Skip to main content
Open Menu

(337) 419-3170

Serving the Lake Charles area
Temporarily Closed During Rebuilding

Home » Your Eye Health » Eye Diseases » Diabetes and Eyesight » Overview of Diabetic Retinopathy

Overview of Diabetic Retinopathy

Diabetic retinopathy involves swelling, leaking or abnormal growth of blood vessels in or near the retina. There are multiple stages to this disease, the earliest of which may not present any symptoms you can see.

Symptoms you can see include dark or black spots in your vision that increase over time, or severely blurred vision due to bleeding within the eye.

That’s why comprehensive eye exams are so important when thinking about diabetes and eye sight—both type 1 and type 2 diabetics are at risk for developing diabetic retinopathy, and the longer you have diabetes, the more likely you are to develop some form of the disease.

Treatments for diabetic retinopathy include replacement of the inner gel inside the eye (called a vitrectomy) and different kinds of laser surgery. A recent clinical trial also suggested that better control of blood sugar levels slows the onset and progression of the disease in many patients.

 

Special thanks to the EyeGlass Guide, for informational material that aided in the creation of this website. Visit the EyeGlass Guide today!

TSO logo

Temporarily Closed During Rebuilding

We are currently working on rebuilding the destruction left behind by the storm, and look forward to being able to service our local community again soon.

If you have an order made before the storm that needs to be picked up or need to reorder contact lenses, please send us a text message to (337) 433-7708 or send us an email to tsolakecharles@hotmail.com.

We do not have a temporary location or office during rebuilding, so please text or email us with any questions or concerns. We will let everyone know when we have a date for reopening.

We sincerely thank you for your patience as we rebuild together as a community, and we wish you a happy and healthy holiday season.